Year
Edition number
№7 / 2017
Reviews
Shatalova E.A., Zubkov V.V., Shmakov R.G., Podurovskaya Yu.L., Kravchenko N.F., Vanko L.V.
Pregnancy after solid organ transplantation: Complications, outcomes, prospects5-11
Khromova E.A., Akhmatova E.A., Kostinova A.M., Cherdantsev A.P., Savisko A.A., Akhmatova N.K.
Impact of influenza vaccination on the course of pregnancy and on fetal and neonatal development12-17
Goncharov N.P., Dedov I.I., Katsia G.V., Gavisova A.A., Sukhikh G.T.
The specific features of metabolism of DHEA and the current possibilities of its use for the correction of reproductive dysfunction18-26
Khechumyan L.R., Kalinina E.A., Donnikov A.E., Kulakova E.V., Ibragimova E.O.
Role of the vitamin K-dependent protein periostin in predicting the effectiveness of an assisted reproductive technology program28-32
Original Articles
Strizhakov A.N., Miryushchenko M.M., Ignatko I.V., Popova N.G., Florova V.S., Kuznetsov A.S.
Prediction of fetal growth restriction in high-risk pregnant women34-44
Bulatova Yu.S., Tetruashvili N.K., Vishnyakova P.A., Vysokikh M.Yu., Marei M.V., Pyataeva S.V., Sukhikh G.T.
Mitochondrial proteins of peripheral plasma microvesicles as biomarkers of early pregnancy losses46-51
Krechetova L.V., Tetruashvili N.K., Vtorushina V.V., Nikolaeva M.A., Khachatryan N.A., Agadzhanova A.A., Vanko L.V., Ivanets T.Yu., Sukhikh G.T.
Characteristics of the phenotype of peripheral blood lymphocytes in women with idiopathic recurrent miscarriage in relation to the outcome of pregnancy during immunocytotherapy52-60
Dobrokhotova Yu.E., Trofimov D.Yu., Shchegolev A.I., Burmenskaya O.V., Veselovskaya Yu.S., Mitrofanova Yu.V., Olenev A.S., Pastarnak A.Yu., Gogichaev T.K.
Placental PIBF1 gene mRNA expression during preterm labor62-67
Vinitsky A.A., Shmakov R.G., Chuprynin V.D.
Comparative evaluation of the efficiency of surgical hemostatic techniques during organ-sparing delivery in patients with placenta increta68-74
G. Sukhikh, I. Baranov, G. Melnichenko, N. Bashmakova, C. Blockeel, G. Griesinger, A. Lomakina, C. Pexman-Fieth
Lotus I: A Phase III randomized controlled trial of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization, with focus on the Russian subpopulation75-95
Dudarova A.Kh., Smolnikova V.Yu., Makarova N.P., Gorshinova V.K., Popova A.Yu., Gamidov S.I., Kalinina E.A.
Different oocyte fertilization methods and their relationship to the effectiveness of assisted reproductive technology programs in the treatment of infertility96-103
Khashchenko E.P., Sukhanova Yu.A., Pyataeva S.V., Volodina M.A., Tarasova N.V., Tsvirkun D.V., Uvarova E.V., Vysokikh M.Yu.
Indicators of mitochondrial functioning in adolescent girls with polycystic ovary syndrome with regard to the presence of metabolic disorders and overweight104-113
Klyucharov I.V., Morozov V.V., Gaineeva Z.A., Klivlend G.O., Ustinova E.M.
The safety and tolerability of Bettocchi operative hysteroscopy in a women’s health clinic114-119
Chugunova L.A., Narogan M.V., Ryumina I.I., Kirtbaya A.R., Gus A.I.
The capabilities of 3D neurosonography in assessing the postnatal formation of the cerebral cortex in very preterm infants120-128
Exchange of Experience
Demikova N.S., Podolnaya M.A., Lapina A.S. Asanov, A.Yu.
Impact of prenatal diagnosis and selective abortions on the frequency of congenital malformations130-135
Guidelines for the Practitioner
Brega E.S., Pekarev O.G.
Options for preparing the cervix uteri for childbirth136-139
Nosenko N.S., Khramchenko N.V.
The course of uncomplicated lower extremity varicose veins during pregnancy140-144
Vladimirova I.V., Donnikov A.E., Makarova N.P., Kalinina E.A.
The use of myo-inositol in the treatment of female infertility in assisted reproductive technology programs in patients at high risk for immature gametes146-149
Gasparyan S.A., Safonova O.A., Nalgieva M.I., Khripunova A.A.
Medicament therapy in the treatment of combined uterine diseases150-154
Clinical Notes
Khizroeva D.Kh., Bitsadze V.O., Makatsaria A.D., Stulyova N.S.
Catastrophic antiphospholipid syndrome during pregnancy155-160
Perinatal prevention of diseases caused by Group B streptococcus (clinical protocol)
161-165
